Trial Profile
A Randomized, Open label, Four Arms Parallel Study to Evaluate the Safety and Efficacy of anti-CD6 monoclonal antibody (T1h mAb) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2019
Price :
$35
*
At a glance
- Drugs Itolizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Biocon
- 03 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 01 Jul 2009 New trial record